findmyKOL
Clinical trialNCT02219178CompletedPhase 2Interventional

Study of the Efficacy and Safety of RsqVD Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma

SponsorCancer Trials IrelandEnrollment42Multiple Myeloma
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study aims to evaluate the overall response rate after 4 cycles and the best response to induction therapy with combination of lenalidomide, subcutaneous bortezomib, and dexamethasone (RsqVD) in patients with newly diagnosed multiple myeloma.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Ireland
  • University Hospital Waterford

    Waterford, Co Waterford, Ireland

  • Cork University Hospital

    Cork, Ireland

  • Beaumont Hospital

    Dublin, Ireland

  • Mater Misericordiae University Hospital

    Dublin, Ireland

  • St James'S Hospital

    Dublin, Ireland

  • University Hospital Galway

    Galway, Ireland

  • University Hospital Limerick

    Limerick, Ireland

  • Midlands Regional Hospital

    Tullamore, Ireland

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Dexamethasone →Subcutaneous bortezomibLenalidomide →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Nov 2014
Primary completion
31 Oct 2019
Completion
30 Apr 2020
Last update posted
17 Jul 2020
Registered enrollment
42
Registry id
NCT02219178

Cross-registrations

EU-CTR / CTIS (EudraCT)2013-005008-32
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 30 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.